Search results for: 'biological 2014'

The world chemical and biological agent detection market report covers all topics related to this industry. The size of the U.S. market, both military and civilian, is discussed in detail. The world market, which, includes European, Asian, and Middle Eastern markets are also covered. While analyzing the market, the total market size as well as mark...

This research service provides insights about the U.S. chemical biological and nuclear detection market.

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...

Next-generation fermentation pathways for sustainable fuel production represent an evolving suite of biological and bio-electrochemical processes designed to convert diverse carbon sources, such as CO₂, biomass, waste gases, and organic residues, into liquid fuels. These approaches integrate advances in metabolic engineering, synthetic biology, and...

This research service considers the biologics market in Brazil. It covers the markets move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key marke...

This study covers the active pharmaceutical ingredients (APIs) market for Singapore, Malaysia, Thailand, Philippines, Indonesia, Vietnam, Australia, and New Zealand. The study is segmented according to the customer base and the ingredients mode of synthesis. The study details the revenue forecasts and market trends for generic, innovative, synthet...

Growth forecasts in 2013 were constantly upgraded or downgraded due to the long-lasting effects of debt in Europe, and stronger performances from the United States and the United Kingdom. Emerging global economies were also beginning to feel the effects of the easing of the US monetary policy; this led to volatility in capital markets globally. For...

This study looks at the outcome of the 2018 Strategy which was introduced by the VW Group in 2010. It then analyzes the recent Strategy 2025 which was rolled out by the group. Key aspects of the new strategy are analyzed and their implications for the overall group and the individual brands are discussed. The study also looks at the various capabil...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...